Quick Answer
NOVARTIS AG reported Total Assets of $110.95 billion for fiscal year 2025.
NOVARTIS AG — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Assets | $110.95B +8.5% |
$102.25B +2.3% |
$99.94B -14.9% |
$117.45B -10.9% |
$131.79B +3.1% |
$127.78B +7.9% |
| R&D Expense | $11.20B +11.8% |
$10.02B -11.9% |
$11.37B +24.0% |
$9.17B +6.1% |
$8.64B -3.8% |
$8.98B -4.5% |
| Gross Profit | $42.98B +10.5% |
$38.90B +13.8% |
$34.19B +7.2% |
$31.88B -1.1% |
$32.24B -7.3% |
$34.78B +1.5% |
- NOVARTIS AG reported Total Assets of $110.95 billion for fiscal year 2025.
- NOVARTIS AG showed an increase of +8.5% in Total Assets compared to the prior fiscal year.
- NOVARTIS AG reported R&D Expense of $11.20 billion for fiscal year 2025.
- NOVARTIS AG showed an increase of +11.8% in R&D Expense compared to the prior fiscal year.
- NOVARTIS AG reported Gross Profit of $42.98 billion for fiscal year 2025.
- NOVARTIS AG showed an increase of +10.5% in Gross Profit compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: